chartexchange

Cognition Therapeutics Announces CTAD Poster Highlighting Screening Efficiencies with p-Tau217 in the Ongoing Phase 2 START Study

GlobeNewswire Inc. | Nov 17, 2026 6:00 AM EST

- Efficient screening processes may reduce participant and site burden in clinical trials -

Read original article